Fabio Mangiacapra1, Micaela Conte2, Chiara Demartini3, Olivier Muller2, Leen Delrue2, Karen Dierickx2, Germano Di Sciascio3, Bruno Trimarco4, Bernard De Bruyne2, William Wijns2, Jozef Bartunek2, Emanuele Barbato5. 1. Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium; Department of Cardiovascular Sciences, Campus Bio-Medico University, Rome, Italy. 2. Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium. 3. Department of Cardiovascular Sciences, Campus Bio-Medico University, Rome, Italy. 4. Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. 5. Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium; Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. Electronic address: emanuele.barbato@olvz-aalst.be.
Abstract
BACKGROUND: Elevated serum levels of asymmetric dimethylarginine (ADMA) are associated with endothelial dysfunction and atherogenesis. In patients with suspected coronary artery disease (CAD), we assessed the correlation of serum ADMA levels with extent and functional significance of coronary atherosclerosis. METHODS: We enrolled 281 patients with suspected CAD undergoing coronary angiogram. Angiographic CAD severity was evaluated by Bogaty score. In patients with angiographic evidence of at least one intermediate coronary stenosis (≥50% diameter stenosis), functional significance was assessed by fractional flow reserve (FFR). Blood samples were collected in all patients prior to coronary angiography for measurement of serum ADMA levels. RESULTS: We observed across tertiles of ADMA levels increasingly higher values of both Stenosis Score (2.25±1.70 vs. 2.89±1.99 vs. 2.95±1.82, p=0.016) and Extent Index (0.52±0.32 vs. 0.61±0.39 vs. 0.72±0.47, p=0.003). The association between ADMA levels and Extent Index remained significant after multivariate adjustment (p=0.005). Patients with FFR ≤0.80 in at least one vessel (n=113) had significantly higher ADMA levels compared with patients without functionally significant CAD (0.51 [0.43-0.64] vs. 0.46 [0.39-0.58]μmol/L, p=0.005). Serum ADMA levels were independent predictors of abnormal FFR after adjustment for extent score (odds ratio 7.35, 95% confidence interval 1.05-56.76, p=0.046). CONCLUSIONS: Serum ADMA levels are independent predictors of coronary atherosclerosis extent and functional significance of CAD.
BACKGROUND: Elevated serum levels of asymmetric dimethylarginine (ADMA) are associated with endothelial dysfunction and atherogenesis. In patients with suspected coronary artery disease (CAD), we assessed the correlation of serum ADMA levels with extent and functional significance of coronary atherosclerosis. METHODS: We enrolled 281 patients with suspected CAD undergoing coronary angiogram. Angiographic CAD severity was evaluated by Bogaty score. In patients with angiographic evidence of at least one intermediate coronary stenosis (≥50% diameter stenosis), functional significance was assessed by fractional flow reserve (FFR). Blood samples were collected in all patients prior to coronary angiography for measurement of serum ADMA levels. RESULTS: We observed across tertiles of ADMA levels increasingly higher values of both Stenosis Score (2.25±1.70 vs. 2.89±1.99 vs. 2.95±1.82, p=0.016) and Extent Index (0.52±0.32 vs. 0.61±0.39 vs. 0.72±0.47, p=0.003). The association between ADMA levels and Extent Index remained significant after multivariate adjustment (p=0.005). Patients with FFR ≤0.80 in at least one vessel (n=113) had significantly higher ADMA levels compared with patients without functionally significant CAD (0.51 [0.43-0.64] vs. 0.46 [0.39-0.58]μmol/L, p=0.005). Serum ADMA levels were independent predictors of abnormal FFR after adjustment for extent score (odds ratio 7.35, 95% confidence interval 1.05-56.76, p=0.046). CONCLUSIONS: Serum ADMA levels are independent predictors of coronary atherosclerosis extent and functional significance of CAD.
Authors: Rushi V Parikh; Vedant Pargaonkar; Robyn L Ball; Yuhei Kobayashi; Takumi Kimura; Alan C Yeung; John P Cooke; Jennifer A Tremmel Journal: Int J Cardiol Date: 2019-07-19 Impact factor: 4.039
Authors: Juraj Madaric; Martina Valachovicova; Ludovit Paulis; Jana Pribojova; Renata Mateova; Katarina Sebekova; Luba Postulkova; Terezia Madaricova; Maria Bucova; Martin Mistrik; Ivan Vulev Journal: Stem Cell Res Ther Date: 2017-07-12 Impact factor: 6.832
Authors: Philip Düsing; Andreas Zietzer; Philip Roger Goody; Mohammed Rabiul Hosen; Christian Kurts; Georg Nickenig; Felix Jansen Journal: J Mol Med (Berl) Date: 2021-01-22 Impact factor: 4.599
Authors: Theodoros Dimitroulas; James Hodson; Aamer Sandoo; Jacqueline Smith; George D Kitas Journal: Arthritis Res Ther Date: 2017-02-10 Impact factor: 5.156
Authors: Davide Firinu; Pier P Bassareo; Angela M Zedda; Maria P Barca; Antonio Crisafulli; Giuseppe Mercuro; Stefano Del Giacco Journal: Front Physiol Date: 2018-05-16 Impact factor: 4.566